Figure 7.
Intracoronary administration of CSCs promotes myocardial regeneration. Regenerated EGFP-positive myocytes in the infarcted region in a CSC-treated heart are labeled with α-sarcomeric actin (red) (A) and EGFP (green) (B). Panel (C) shows the combination of EGFP and α-sarcomeric actin (yellow-green).